Maybe the sell down was by one of the top shareholders to fund ongoing Midkine trials as the Evolis sales may not be producing the income to keep the trials going. Guess you guys will find out soon enough..
CDY Price at posting:
21.0¢ Sentiment: None Disclosure: Not Held